These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22709576)

  • 1. Modulation of beta-amyloid aggregation by engineering the sequence connecting beta-strand forming domains.
    Hu Y; Zheng H; Su B; Hernandez M; Kim JR
    Biochim Biophys Acta; 2012 Oct; 1824(10):1069-79. PubMed ID: 22709576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
    Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creation of aggregation-defective α-synuclein variants by engineering the sequence connecting β-strand-forming domains.
    Hernandez M; Golbert S; Zhang LG; Kim JR
    Chembiochem; 2011 Nov; 12(17):2630-9. PubMed ID: 21998035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
    Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Abeta fibril formation pathway.
    Lee S; Fernandez EJ; Good TA
    Protein Sci; 2007 Apr; 16(4):723-32. PubMed ID: 17327396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peptide probe for detection of various beta-amyloid oligomers.
    Hu Y; Su B; Zheng H; Kim JR
    Mol Biosyst; 2012 Oct; 8(10):2741-52. PubMed ID: 22832997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
    Wu WH; Liu Q; Sun X; Yu JS; Zhao DS; Yu YP; Luo JJ; Hu J; Yu ZW; Zhao YF; Li YM
    Biochem Biophys Res Commun; 2013 Sep; 439(3):321-6. PubMed ID: 24012671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the central region containing residues 19-25 on the aggregation properties and secondary structure of Alzheimer's beta-amyloid peptide.
    El-Agnaf OM; Guthrie DJ; Walsh DM; Irvine GB
    Eur J Biochem; 1998 Sep; 256(3):560-9. PubMed ID: 9780232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectroscopic evidence for polymorphic aggregates formed by amyloid-β fragments.
    Guo Y; Wang J
    Chemphyschem; 2012 Dec; 13(17):3901-8. PubMed ID: 23112008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
    Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P
    J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicity.
    Liao YH; Chang YJ; Yoshiike Y; Chang YC; Chen YR
    Small; 2012 Dec; 8(23):3631-9. PubMed ID: 22915547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
    Poduslo JF; Howell KG
    J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembly pathways of E22Δ-type amyloid β peptide mutants generated from non-aggregative O-acyl isopeptide precursors.
    Sohma Y; Wang H; Taniguchi A; Hirayama Y; Kakizawa T; Yamasaki M; Mukai H; Kiso Y
    Bioorg Med Chem; 2011 Jun; 19(12):3787-92. PubMed ID: 21612934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key residues for the oligomerization of Aβ42 protein in Alzheimer's disease.
    Ngo S; Guo Z
    Biochem Biophys Res Commun; 2011 Oct; 414(3):512-6. PubMed ID: 21986527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization.
    Candreva J; Chau E; Rice ME; Kim JR
    Biochemistry; 2020 Feb; 59(4):425-435. PubMed ID: 31854188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
    Thal DR; Walter J; Saido TC; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.